(Q36238737)

13 August 2017

1 reference

title

Regulatory issues for plant-made pharmaceuticals and vaccines (English)

1 reference

13 August 2017

author name string

Stephen J Streatfield

series ordinal

1

1 reference

13 August 2017

publication date

1 August 2005

1 reference

Expert Review of Vaccines

13 August 2017

published in

1 reference

13 August 2017

volume

4

1 reference

13 August 2017

issue

4

1 reference

13 August 2017

page(s)

591-601

1 reference

On risk and plant-based biopharmaceuticals.

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.591

Comparing N-glycan processing in mammalian cell lines to native and engineered lepidopteran insect cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.591

Appropriate glycosylation of recombinant proteins for human use: implications of choice of expression system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.591

Monoclonal antibody manufacturing in transgenic plants--myths and realities

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.591

Screening for glycosylation changes on recombinant human IgG using lectin methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.591

Delivery of subunit vaccines in maize seed.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.591

Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.591

Human immune responses to a novel norwalk virus vaccine delivered in transgenic potatoes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.591

Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.591

Immunogenicity in humans of an edible vaccine for hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.591

Sialylated endogenous glycoconjugates in plant cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.591

A murine monoclonal antibody produced in transgenic plants with plant-specific glycans is not immunogenic in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.591

Galactose-extended glycans of antibodies produced by transgenic plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.591

Production of recombinant proteins in transgenic plants: Practical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.591

Expression of a functional antizearalenone single-chain Fv antibody in transgenic Arabidopsis plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.591

Considerations for the recovery of recombinant proteins from plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.591

Production of antibodies in transgenic plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.591

Virus-like particle expression and assembly in plants: hepatitis B and Norwalk viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.591

Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.591

Affinity-purification of a TMV-specific recombinant full-size antibody from a transgenic tobacco suspension culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.591

Transgenic plants in the biopharmaceutical market.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.591

Milestones in chloroplast genetic engineering: an environmentally friendly era in biotechnology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.591

Transient expression of a tumor-specific single-chain fragment and a chimeric antibody in tobacco leaves

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.591

Plant production systems for vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.591

Chemically regulated gene expression in plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.591

Selectable marker-free transgenic plants without sexual crossing: transient expression of cre recombinase and use of a conditional lethal dominant gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.591

Downstream processing of recombinant proteins from transgenic feedstock

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.591

Rice cell culture as an alternative production system for functional diagnostic and therapeutic antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.591

21 January 2018

Identifiers

DOI

10.1586/14760584.4.4.591

1 reference

13 August 2017

1 reference